. . . "desferrioxamine from each countryThe questionnaire asked respondents to provide information about the frequency of missed doses, taking a higher or lower dose of desferrioxamine than was prescribed during the preceding month, and the sources of help to continue taking the drug regularly (i.e., doctor, health care providers, family, friends, other patients, thalassemia association or other sources)" . . .